Leading biotechnology company in regenerative medicine and advanced therapies (gene and cell therapy) are looking to recruit an Interim Chief Scientific Officer/Head of R&D with significant ATMP (Advanced Therapy Medicinal Product) development experience.
To drive an effective drug development strategy. Plan, coordinate and lead activities simultaneously on multiple programmes.
• Have experience of gene and/or cell therapy drug development.
• Experience of creating cohesive Development Plans/Strategies to support fundraising for early stage biotech’s – experience of presenting to investors.
• Experience of working with early stage biotech companies; creating plans and fundraising models, with the willingness to be both strategic and hands-on where
resources and infrastructure is limited.
• Experience of reviewing therapeutic opportunities/indications and making sound scientific recommendations/business cases to the Board and investors on which
opportunities to advance.
Duration and days per week: 3-6 months, 3-4 days per week
Keywords: Chief Scientific Officer, CSO, Leadership, Fundraise, Cell Therapy, Gene Therapy, Biotech, Biotechnology, Advanced Therapies, Series A, ATMP, Advance Therapy Medicinal Product, R&D, Drug Development.
To register your interest in this opportunity please forward an up-to-date CV to email@example.com or contact Sarah Lloyd on 01480 499580, quoting reference 882543 and advising current availability and anticipated day rate.